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Abstract 
Clinical evidence links arterial calcification and cardiovascular risk. Finite-element 
modelling of the stress distribution within atherosclerotic plaques has suggested 
that subcellular microcalcifications in the fibrous cap may promote material failure 
of the plaque, but that large calcifications can stabilize it. Yet the physicochemical 
mechanisms underlying such mineral formation and growth in atheromata remain 
unknown. Here, by using three-dimensional collagen hydrogels that mimic 
structural features of the atherosclerotic fibrous cap, and high-resolution 
microscopic and spectroscopic analyses of both the hydrogels and of calcified 
human plaques, we demonstrate that calcific mineral formation and maturation 
results from a series of events involving the aggregation of calcifying extracellular 
vesicles, and the formation of microcalcifications and ultimately large calcification 
zones. We also show that calcification morphology and the plaque's collagen 
content – two determinants of atherosclerotic plaque stability - are interlinked. 
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Calcification morphology determines plaque stability  
 
A material failure of the collagen-poor fibrous cap contributes critically to 
atherosclerotic plaque rupture1, a global leading cause of death2. Understanding 
plaque integrity can benefit from connection of cellular changes to alterations in 
tissue material properties. Classically, plaque vulnerability associates with low 
collagen content in the fibrous cap, which compromises its tensile strength3,4. 
Recent computational studies, however, highlight the presence of destabilizing 
microcalcifications (approximately 5 µm), smaller than the resolution limits of 
traditional clinical imaging modalities (currently >30 µm), in the cap of “vulnerable 
plaques” as a determinant of their biomechanical failure5-7. Indeed, coronary 
calcium scores predict acute cardiovascular events better than traditional risk 
calculators8,9. Plaque rupture occurs when local stresses exceed a critical 
threshold for material failure, compromising the structural integrity of the fibrous 
cap. The formation of microcalcifications causes plaque instability by promoting 
high stress accumulation within the cap extracellular matrix (ECM)10, likely 
favouring cavitation events that occur due to the large modulus mismatch between 
the small, stiff microcalcifications and the surrounding hyperelastic collagen5,6.  
Prospective clinical data from the Multi-Ethnic Study of Atherosclerosis trial, which 
showed that the abundance of arterial calcification per arterial volume correlates 
inversely with cardiovascular events11, corroborates the biomechanical model 
predictions linking microcalcifications with plaque rupture. These data indicate that 
larger calcifications may stabilize atherosclerotic plaques12-15, whereas “spotty” 
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calcification (>30 µm) may indicate the presence of active remodeling and clinically 
undetectable microcalcifications (1 µm -30 µm) that contribute to plaque 
destabilization16. Thus, the calcification morphology correlates with cardiovascular 
risk. Yet, mechanisms that govern the formation of microcalcifications and larger, 
potentially plaque-stabilizing calcifications remain unknown.  
Nano-analytical electron microscopy revealed structural detail of calcific mineral 
within cardiovascular tissues17. The formation of large zones of calcification and of 
microcalcifications may involve cell-derived extracellular vesicles (EVs) that serve 
as nucleating foci for mineralization18-20.  Emerging evidence suggests that 
vascular calcification involves calcifying EVs released from vascular smooth 
muscle cells (SMCs) and macrophages18-20, implying that atherosclerotic plaques 
contain continuous sources of precursors of microcalcification. Yet, the process by 
which EVs contribute to vascular calcification remains unclear due to the inability to 
visualize and monitor early calcification events in vivo. Microcalcifications that 
create inhomogeneities in the fibrous cap cause a local accumulation of plaque-
destabilizing stress5, and therefore, understanding the contribution of this stress to 
plaque rupture requires a detailed study of the relationship between extracellular 
matrix components and microcalcification formation by EVs. In silico modeling 
indicates that calcification size, morphology, spacing, and collagen content 
combined contribute to plaque instability5. The present study aimed to understand 
the interaction of these factors by focusing on the mechanisms underlying the 
formation of the pathologic calcification, from microcalcifications to large 
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calcifications. Advanced high-resolution imaging and material analysis techniques 
allowed for the characterization of human and mouse atherosclerotic plaques and 
an in vitro three-dimensional (3-D) type I collagen hydrogel designed to mimic 
structural features of an atherosclerotic fibrous cap, served to permit direct 
observation of the processes of EV calcification nucleation and maturation. The 
results provide physicochemical mechanistic insight into the formation of plaque 
microcalcifications and the role of collagen in mediating this process. 
 
Inverse correlation between collagen and calcification 
High-resolution microcomputed tomography (µCT) revealed two different 
calcification morphologies within intact human coronary atherosclerotic plaques: 
microcalcifications (Fig. 1a, arrows) and large calcifications (Fig. 1b, dashed arrow). 
Microcalcifications can localize to the fibrous caps (Fig. 1a, yellow arrow). Deeper 
within the plaques microcalcifications appear to localize preferentially at regions 
corresponding to the borders of the lipid pool21 (Fig. 1a, white arrow) and surround 
the large calcifications (Fig. 1b). Study of human carotid plaques showed similar 
calcification features (Fig. 1c). A 3-D reconstruction of µCT sections showed 
inhomogeneity of calcification throughout the vessel wall with regions of small (Fig. 
1d, yellow arrow) and large calcifications (Fig. 1d, dashed arrow).  
Using co-staining of von Kossa, identifying calcification, and picrosirius red, 
visualizing collagen under polarized light, this study assessed the relationship 
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between collagen fiber structural organization and calcification morphology in 
human carotid atherosclerotic plaques (Fig. 1e-f). Overlapped images reveal large 
calcifications (> 200 µm) bordered by mature, aligned collagen fibers, as indicated 
by yellow-orange birefringence (Fig. 1e, 1f). A magnified polarized image of the 
region depicted by the white box shows dense, mature collagen fibers adjacent to 
the large calcification (Fig. 1g, dashed arrow). While not apparent in the low 
magnification images (Fig. 1e, red box), magnified images reveal 
microcalcifications stained brown-black by von Kossa (Fig. 1h, arrow). 
Microcalcifications localized to regions lacking collagen (Fig. 1i, arrow). Custom 
image analysis software color-coded thick collagen fibers red, thin collagen fibers 
green, and microcalcifications blue, allowing for the visualization of 
microcalcifications directly adjacent to collagen fibers (Fig. 1j, arrow).   
Two-photon microscopy provided whole mount imaging of human carotid arteries. 
Optical sections of second harmonic generation signal from collagen fibers and 
near-infrared fluorescent calcium tracer signal were acquired from the luminal 
surface into the plaque, allowing observation of microcalcifications beneath the 
fibrous cap (Fig. 2a, yellow arrow) and a larger calcification deeper within the 
plaque (Fig. 2a, white arrow). A 3-D reconstruction viewed orthogonally to adjacent 
optical sections reveals microcalcifications within the fibrous cap as close as 20 µm 
from the lumen (Fig. 2b).  
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Confocal microscopy provided high-resolution, high-magnification imaging of 
plaque collagen and calcification within histologically sectioned carotid arteries (Fig. 
2c). A custom green fluorescent agent22 visualized collagen fibers and the near-
infrared agent demonstrated calcification. Confocal images revealed abundant 
microcalcifications throughout the fibrous cap. The microcalcifications within the 
fibrous cap appeared to aggregate in gaps between collagen fibers and appeared 
as discrete spheres less than 1 µm in diameter (Fig. 2c, arrows). Pearson 
correlation analysis revealed an inverse relationship between microcalcification 
area and collagen content within the analyzed regions of 200 µm2 within the fibrous 
cap (Fig. 2d, n=9 patients, 24 regions per plaque, r=-0.29, p=0.01). 
Microcalcifications previously predicted to produce significant fibrous cap stress 
(~20 µm2)5,6 mainly localized in regions of low collagen content. The mean local 
collagen abundance of these microcalcifications was 16.5±14.8%. 
Microcalcifications surrounded regions of large calcifications (Fig. 2e).  
 
EV aggregation correlates with mineralization 
Density-dependent color scanning electron microscopy17 (DDC-SEM, Fig. 3a) 
revealed structural heterogeneity within large calcific regions (orange hue indicates 
regions corresponding to calcium phosphate mineral) of a histological section of a 
carotid artery plaque. A magnified DDC-SEM image revealed small calcium 
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phosphate-rich microcalcification spheres (<1 µm in diameter) appearing to 
aggregate to form the larger calcific region (Fig. 3b, arrow).  
To test the hypothesis that the nucleation and growth of calcification depends on 
calcification and aggregation of cell-derived EVs, we developed a 3-D in vitro 
preparation to visualize these processes. Conditioned media containing EVs were 
collected over the course of 24 h from SMCs cultured in calcifying media and 
added to collagen hydrogels. After 72 h incubation with the collagen hydrogels, 
DDC-SEM revealed aggregation of EVs between collagen fibers (Fig. 3c), forming 
dense calcifying structures resembling those observed within calcified human 
plaques (Fig. 3b). Confocal reflection microscopy in gaps between collagen fibers 
identified EV aggregates (Fig. 3d, yellow arrow), which contained regions of 
calcification as detected by calcium tracer (Fig. 3d, insert). Supplemental Fig. 1 
illustrates confirmation of the cellular origin of EV aggregates. Calcifying EV 
aggregates did not form in hydrogels incubated with EVs collected from SMCs 
cultured in control media. 
Structured illumination super-resolution microscopy visualized aggregation and 
calcification of fluorescently labeled EVs (Fig. 3e-g). This technique allowed the 
visualization of objects the size of individual EVs (approximately 200 nm in 
diameter) localized within the collagen hydrogels (Fig. 3e, arrow). On these images, 
EVs appear to aggregate to produce spherical calcifying structures as indicated by 
a near-infrared fluorescent calcium tracer (Fig. 3f, g). 
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An image analysis algorithm assessed the volume of the aggregates identified by 
confocal reflection microscopy optical sections of the collagen hydrogels after 72 h 
incubation with the calcifying samples. Increasing the collagen concentration within 
the hydrogels reduced the average aggregate size by 90% compared to the 
samples without collagen (ANOVA, p<0.001).  
We further explored the relationship between EV aggregation and mineral growth 
using nanoparticle-tracking analysis (NTA). After 1 day of incubation, EVs exhibited 
a size distribution profile corresponding to that previously described for calcifying 
EVs23 (Fig. 3i, black line), and showed a shift to larger sizes over time, indicating 
EV aggregation (Fig. 3i, red line). Considerable aggregation occurred at the 5 and 
7-day incubation times (Fig. 3j). The shift in diameters measured by NTA 
corresponds to a concomitant increase in calcific mineral in the EVs quantified 
using a fluorescent-based detection23 (Fig. 3k). The mineral content rose in 
calcifying vs. control samples after 5 and 7 days of incubation (p< 0.001). EVs 
obtained from control samples did not aggregate during the 7-day incubation 
(Supplemental Fig. 2). 
Spectroscopic analytical methods provided insight into the mineral produced by 
aggregating EVs in vitro. Energy-dispersive x-ray spectroscopy (EDS) revealed 
that both small and large dense aggregate structures (Fig. 4a) contained high 
concentrations of both calcium and phosphate (Fig. 4a, inserts). EDS 
measurements obtained from a calcified human plaque revealed a calcium-
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phosphate ratio of 1.79±0.28 from microcalcifications and a ratio of 1.87±0.11 from 
large calcifications (n=8 per group), suggesting the presence of amorphous 
calcium phosphate mineral17. Following a 3-day incubation period, the calcium-
phosphate ratio was 1.37±0.13, which increased to 1.94±0.02 after 5 days and 
1.84±0.11 after 7 days, closely matching the values observed in the tissue 
(Supplemental Fig. 3). Previous studies suggested the amorphous nature of 
calcium phosphate mineral deposited in vascular tissues17. Similarly, TEM images 
of the calcifying EVs reveal an amorphous internal structure (Fig. 4b, c) with lower 
crystallinity, as shown by selected-area electron diffraction (Fig. 4b, insert).  
Fourier transform infrared (FTIR) spectroscopy correlated EV aggregation with 
mineral composition, and the resulting spectra were compared with those obtained 
from a calcified carotid artery (Fig. 4d-g). Collagenase digestion of the EV-seeded 
hydrogels visualized calcific mineral as white crystalline structures (Fig. 4d, yellow 
arrows). Within a human carotid plaque (Fig. 4e), von Kossa staining revealed both 
microcalcifications (Fig. 4f, blue arrow) and large calcifications (Fig. 4f, red arrow). 
The FTIR spectrum from a sample of EVs isolated directly from SMCs in calcifying 
culture was considered as the initial time point without incubation in collagen 
hydrogels (Fig. 4g, Day 0). The remaining EVs in culture media were subsequently 
either placed directly into chambers (Fig. 4g, no collagen, lightest blue) or added to 
hydrogels with collagen concentrations of 0.1 mg/ml (Fig. 4g, medium blue) or 1 
mg/ml (Fig. 4g, dark blue). The FTIR spectra after 1 or 5 day incubations were 
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compared to the spectra from the human plaque microcalcification (Fig. 4g, 
Calcified Tissue, blue) and large calcification (Fig. 4g, Calcified Tissue, red).  
A decrease in a FTIR absorbance peak at 1080 cm-1 and the appearance of 
absorbance peaks at 1020 cm-1 and 600 cm-1 signified calcific mineral maturation 
over the course of the 5-day incubation period in the EVs not added to collagen 
(Fig. 4g, lightest blue spectra). An absorbance peak at 875 cm-1 also increased in 
magnitude over the incubation period. These spectra changes agree with spectra 
for maturation of synthetic amorphous calcium phosphate24,25. Increasing collagen 
concentration in the hydrogels slowed calcification maturation over the course of 5 
days. The FTIR spectrum from large calcification within human tissue revealed 
strong absorbance peaks at 1020 cm-1, 875 cm-1, and 600 cm-1 (Fig. 4g, Calcified 
Tissue, red), resembling the maturing mineral spectrum of EVs after 5 days with no 
collagen (Fig. 4g, Day 5, lightest blue). The FTIR spectrum from microcalcification 
within human plaque showed weaker peaks at 1080 cm-1 and 1020 cm-1 (Fig. 4g, 
Calcified Tissue, blue), resembling the immature spectra of EVs within the collagen 
hydrogels. The observed correlation between mineral spectra maturity, aggregation 
time (in vitro), and calcification morphology (in vivo) indicates that 
microcalcifications serve as precursors to larger calcifications within the 
atherosclerotic plaque. 
 
Collagen directs EV aggregation and calcification growth 
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These observations indicate that collagen acts as a scaffold, directing the 
aggregation and calcification of EVs. The establishment of a layered hydrogel 
structure to mimic the heterogeneity in collagen density observed in vivo helped 
demonstrate the effect of collagen on calcification morphology and growth 
(Supplemental Fig. 4). A high-density collagen hydrogel (2.5 mg/ml) overlapped 
with a low-density collagen hydrogel (0.1 mg/ml) created a continuous border (Fig. 
5a). The addition of green fluorescently labeled EVs in calcifying media to the 
layered hydrogels, followed by blue-labeled EVs added 24 h later, helped monitor 
EV aggregation over time. Aggregates of green-labeled EVs and a few blue-
labeled EVs localized throughout the low-density hydrogel and at the borders, but 
not within the high-density hydrogel at the 3-day mark (Fig. 5b, arrows). At day 7, 
aggregates containing calcified EVs labeled with both fluorophores aligned along 
the border of two collagen systems (Fig. 5c, arrows). These data paralleled the 
microcalcification alignment observed in human plaques using µCT. 
Previous studies indicate that calcifying EVs trapped in an endogenous collagen 
matrix lead to mineral deposition in bone cell cultures26,27. Picrosirius red 
absorbance28 demonstrated an increase in collagen accumulation in 21-day 
cultures of SMCs in calcifying media versus SMCs cultured in control media (Fig. 
5d, p<0.05). After 14 days in calcifying media, a 3-D reconstruction of a confocal z-
stack revealed the green fluorescently stained collagen fibers (Fig. 5e). Similar to 
the structures detected in human plaques, small microcalcifications entrapped by 
the collagen matrix appeared to merge, forming larger calcifications. After 21 days 
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in calcifying media, both collagen fiber content and calcification area increased (Fig. 
5f), revealing collagen entrapment of underlying calcification (Fig. 5g). A 
representative optical section taken by confocal microscopy shows the absence of 
calcification and collagen in control media cultures (Fig. 5h). A similar section 
obtained from SMCs in calcifying media illustrates small, spherical regions of 
calcification surrounding the SMCs, and orthogonal views of the confocal stack 
demonstrate the entrapment of the calcifications within collagen fibers (Fig. 5i). A 
magnified image of the calcified structures demonstrates aggregation of smaller 
substructures that lead to the mineral growth (Fig. 5j). 
Apolipoprotein E–deficient (Apoe-/-) mice on an atherogenic diet, develop 
calcification29, and served to assess the role of collagen in mediating calcification 
growth in vivo. Longitudinal studies using intravital imaging of an intravenously 
injected near-infrared calcium tracer monitored progression of calcification growth 
in mouse carotid arteries. Quantification of the fluorescent signal shows a 
significant increase in calcification area from 20 to 30 weeks (Fig. 6b, n=6, p=0.04). 
Chronic kidney disease (CKD) accelerates the progression of calcification30. 
Fluorescence reflection imaging29,31 helped image total aortic calcification in Apoe-/- 
mice and Apoe-/- mice with CKD induced by 5/6 nephrectomy. Accordingly, CKD-
Apoe-/- mice exhibited a significant 6.1-fold increase in mean calcification area 
when compared to Apoe-/- mice (Supplemental Fig. 5, n=6 per group, p<0.001).  
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A method commonly employed to detect the kinetics of bone remodeling32 served 
to probe the conversion from microcalcifications to larger calcifications 
(Supplemental Fig. 6). The study used two different fluorescent calcium tracers 
injected intravenously into Apoe-/- mice: a calcein injection following 20 weeks of 
atherogenic diet and alizarin red S injection 3 weeks later. Imaging the green 
(calcein) and red (alizarin red S) fluorescence by confocal microscopy provided 
snapshots of the state of the aortic calcification at 20 and 23 weeks. Observations 
within the histological sections revealed green microcalcifications at 20 weeks (Fig. 
6c, arrow) fully embedded within the alizarin red stained larger calcification that 
was formed by 23 weeks (Fig. 6c, dashed arrow). These data show that the 
microcalcifications present at the start of calcification become the core of the larger 
calcifications that develop over time. 
The assessment of Apoe-/- mice and Apoe-/- mice deficient in matrix 
metalloproteinase 13 (MMP-13), a major collagen-degrading enzyme, allowed for 
the study of the role of collagen in mediating calcification growth in vivo33. Both 
groups consumed an atherogenic diet for 24 weeks, and were sacrificed and 
analyzed for collagen and calcification by histology. Consistent with previous 
studies33, these mice exhibited increased plaque collagen content (Fig. 6d). Large 
calcifications solely formed in spaces between collagen fibers in Apoe-/- mice (Fig. 
6d, arrows). Quantification of the inter-collagen spacing in each group shows 
significantly larger gaps in Apoe-/- mice compared to compound mutant Apoe-/-
/Mmp13-/- mice (Fig. 6e, n=8, p=0.03). The larger gaps between collagen fibers 
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correlated to significantly larger calcification detected in the plaques of Apoe-/- mice 
than in the plaques of Apoe-/-/Mmp13-/- mice (Fig. 6f, p=0.01). A histochemical stain 
for tissue non-specific alkaline phosphatase activity, an established marker of 
osteogenic activity, revealed no significant difference in the calcification potential of 
atherosclerotic plaques from Apoe-/- and Apoe-/-/Mmp13-/- mice (Supplemental Fig. 
7a,b, p=0.11). Dissolution of mineral within the plaques using hydrochloric acid 
also showed no differences in overall calcium content between Apoe-/- and Apoe-/-
/Mmp13-/- mice (Supplemental Fig. 7c, p = 0.91). These data indicate that, although 
similar calcification potentials exist between the two groups, the increased collagen 
in Apoe-/-/Mmp13-/- mice significantly inhibits calcification growth. 
 
Local collagen determines calcification morphology 
Similar to previous studies, multimodal imaging of human atheroma reveal both 
large calcifications and spotty microcalcifications (Fig. 1, 2, 4), including potentially 
destabilizing microcalcifications within the fibrous cap (Fig. 1a, 2b, 2c). Clinical 
data and computational studies suggest that features of atherosclerotic plaque 
stability depend on calcification size and morphology and the fibrous cap collagen 
content5. The present study shows that microcalcification and collagen degradation, 
two factors that contribute to plaque rupture, interrelate. We documented an 
inverse relationship between collagen and the size of microcalcifications in human 
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atherosclerotic plaques and 3-D hydrogel preparations. These observations 
suggest that thinning of the fibrous cap accompanies microcalcification formation.  
Microcalcification nucleation and growth occurs in four stages (Fig. 6g, insert). 
Localized collagen degradation within the plaque allows individual EVs to 
accumulate (Accumulation, Stage 1), followed by EV aggregation (Aggregation, 
Stage 2). Similar to processes previously described for fusion of liposomes34,35, 
nucleation of calcium phosphate leads to fusion of the EV membranes (Fusion, 
Stage 3). Microcalcifications form due to the maturation of this mineral 
(Mineralization, Stage 4). Local collagen degradation within the cap thereby allows 
localized EV aggregation resulting in microcalcification formation (Fig. 6g). Matrix 
metalloproteinases, including macrophage-derived MMP-13, contribute to the 
paucity of fibrillar collagen36 and even promote calcification37. Indeed, data from 
the present study show decreased size of calcified regions in the atherosclerotic 
plaques of Apoe-/-/Mmp13-/- mice.  
When unencumbered by collagen, microcalcifications serve as building blocks for 
larger calcifications. In human tissue, microcalcifications compose large 
calcifications, and experiments using injections of two calcium tracers in Apoe-/- 
mice show that microcalcifications present at 20 weeks of atherogenic diet 
coalesce into larger regions of calcification 3 weeks later. Therefore, 
microcalcifications and large calcifications exist as part of a continuum. The most 
important consideration is the contribution of individual calcifications to the 
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mechanical stability of plaques. Computational analyses indicate that 
microcalcifications of approximately 5 µm in diameter that localize within a 
collagen-poor fibrous cap, increase mechanical stress within the hyperelastic 
tissue surrounding microcalcification inclusions and favor rupture. While the 
theoretical analysis of explosive growth of small voids occurs when the local tissue 
stress exceeds the local Young’s modulus of the tissue, this growth is unlikely to 
occur if the microcalcifications are smaller than 5 µm. Notably, microcalcifications 
formed in the collagen hydrogels used in this study often approached the size 
threshold previously calculated to lead to plaque destabilization5,6.  
Previous studies also demonstrated that elongated ellipsoidal microcalcifications 
result in significantly higher stress at the poles of the long axis than spherical 
microcalcifications38. The present study’s results indicate that these structures form 
by aggregation of adjacent microcalcifications between collagen fibers, and that 
alignment of collagen within the fibrous cap facilitates association of the 
microcalcifications to assume this elongated morphology. The current study did not 
assess the direct physical interaction between collagen and calcification, and the in 
vitro structures did not include factors that may mediate this interaction such as 
proteoglycans. Future work on the mechanisms of calcification incorporation into 
the tissue may enhance the understanding of the physical phenomena that favor 
plaque rupture.  
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Future studies into the role of plaque lipids and matrix changes on cellular behavior 
will be important in identifying points of therapeutic intervention. Collagen 
accumulation and large calcification in fibrous caps increases the tensile strength 
of the plaques39 but also increases the total plaque stiffness. Recent findings 
suggest that oxidized LDL cholesterol can induce SMCs to adopt a calcific 
phenotype40 and that cells undergo osteogenic differentiation following matrix 
stiffening41. Elucidating these mechanisms will provide insight into the cellular 
source of calcifying extracellular vesicles within the plaque. 
 
Outlook 
The approaches used here can enable future studies to control mineral nucleation 
and growth in a search for therapeutic strategies to limit vascular calcification. Most 
clinical studies of calcification use intravascular ultrasound, magnetic resonance, or 
optical coherence tomography imaging. These techniques have a lower resolution 
threshold of 30-50 µm, limiting their ability to identify high-risk microcalcifications. 
Advanced imaging techniques that can identify inflammation and calcification within 
potentially vulnerable plaques in patients now exist42. New insight into the 
mechanisms associated with calcification formation and growth may inform clinical 
decisions into appropriate interventions in these patients. Gaining this insight will 
continue to require detailed analyses on the impact of calcific remodeling on tissue 
material properties and plaque instability.  
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Local stress maxima directly adjacent to microcalcifications within the fibrous cap 
induce plaque rupture5,38. Future studies may build on the current work by using 
nano-analytical techniques such as atomic force microscopy to probe the local 
stresses in the extracellular matrix surrounding microcalcifications. Many previous 
computational studies have modeled the fibrous cap as a homogenous 
hyperelastic material5,6. These analyses have provided important insight into our 
initial understanding of the role of microcalcifications in plaque rupture. The current 
study, however, illustrates the inhomogeneity of the extracellular matrix 
surrounding microcalcifications and the importance of local collagen remodeling in 
microcalcification formation. Therefore, new analyses into the stresses associated 
with this localized remodeling may help to refine the computational models and 
provide insight into means to therapeutically alter the stresses by targeting local 
extracellular components, thereby preventing plaque failure. 
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Figures 
Fig. 1. Identification of calcific morphologies within human atherosclerotic plaques. 
a) Apical view from a µCT scan of a coronary artery with microcalcifications 
throughout the plaque (white arrow) and in the fibrous cap (yellow arrow). b) Apical 
view from a µCT scan of a coronary artery with large calcification (dashed arrow). 
c) Apical view from a µCT scan of a carotid artery with large calcification (dashed 
arrow) and microcalcifications (yellow arrow). d) Three-dimensional reconstruction 
of µCT sections of a carotid artery with large (dashed arrow) and small (yellow 
arrow) calcifications. e) Composite bright field image of a histological section of a 
human carotid artery with an atherosclerotic plaque. Von Kossa staining was used 
to identify regions of calcification (arrow, scale = 500 µm). f) Composite polarized 
image of a histological section of a human carotid artery with an atherosclerotic 
plaque. Picrosirius red staining helped identify collagen fibers (scale = 500 µm). g) 
Magnified polarized image of large calcification region (dashed arrow, scale = 25 
µm). h) Magnified bright field image revealing microcalcification (arrow, scale = 25 
µm). i) Polarized image of microcalcification region (arrow, scale = 25 µm). j) Bright 
field and polarized image overlay with digital pseudo-color showing mature 
collagen (red), immature collagen (green), and microcalcifications (blue, arrow). 
Fig. 2. Collagen and calcification structure in human carotid artery atherosclerotic 
plaques. a) Two-photon microscopy second harmonic generation of collagen 
(green) overlayed with continuous wave confocal microscopy identification of a 
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near-infrared calcium tracer (red) in a calcified human carotid atherosclerotic 
plaque. (scale = 20 µm) b) Orthogonal view of 3-dimensional reconstruction of two-
photon and continuous wave confocal z-stacks demonstrating the fibrous cap 
(white arrow) with microcalcifications (yellow arrows). c) Confocal optical section of 
microcalcifications (arrows) within a human carotid artery fibrous cap stained with a 
near-infrared calcium tracer (red) and a custom collagen probe (green). (scale = 20 
µm) d) Quantification of collagen content surrounding microcalcifications identified 
across 9 different human plaques. Correlation determined by Pearson method (red 
line, n=9, p=0.01). e) Confocal 3-dimensional reconstruction of optical sections of a 
large calcification within a human carotid artery plaque stained with a near-infrared 
calcium tracer (red) and a custom collagen probe (green). (scale = 20 µm) 
Fig. 3. EV aggregation and calcification in calcified tissue and in vitro. a) DDC-
SEM of a large calcification within a human carotid artery plaque section. (scale = 2 
µm) b) Magnified image of large calcification using DDC-SEM. (scale = 500 nm) c) 
DDC-SEM of calcifying EVs within a synthetic collagen hydrogel. (scale = 500 nm)  
d) Confocal reflection optical section of an aggregate structure observed between 
collagen fibers (yellow arrow) in a collagen hydrogel with calcification stained by a 
near-infrared calcium tracer (insert) within aggregate structure. (scale = 2 µm) e) 
Super-resolution structure illumination microscopy of aggregate of individual 
fluorescently labeled EVs (arrow). f) Near-infrared calcium tracer signal (arrow) 
observed using super-resolution structure illumination microscopy of fluorescently 
labeled EV aggregate. g) EV fluorescence and near-infrared calcium tracer overlay 
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from super-resolution structure illumination microscopy images (scale = 500 nm). 
h) Aggregation occurred on the surface of the culture well plates in the absence of 
collagen with an average aggregate volume of 4,567 µm3. Adding the conditioned 
media to hydrogels composed of 0.1 mg/ml collagen, led to a 33% reduction in the 
size of the aggregates formed. Increasing the collagen concentration within the 
hydrogels to 1 mg/ml further reduced the average aggregate size by 90% 
compared to the samples without collagen (n = 4 independent experiments, 
ANOVA, * signifies p < 0.05, *** signifies p < 0.001). i) Nanoparticle tracking 
analysis (NTA) histogram of size distribution of EVs incubated at 37 oC for 1 (black 
line) or 7 days (red line). j) By dividing the objects detected by NTA into 100 nm 
bins, the mean diameter measured by NTA increased from 156.2±16.4 nm at day 1 
to 199.5±27.1 nm at day 5 and 214.7±44.5 nm at day 7. The percentage of 
aggregates with a diameter larger than 300 nm increased from 4.4±2.4% at day 1 
to 14.8±11.9% at day 5 and 22.5±10.6% at day 7. (n = 3 independent experiments). 
k) Quantification of mineralization of control (black line) and calcifying EVs (red 
line) incubated for 0, 1, 3, 5, or 7 days. (n = 3 independent experiments, ANOVA, 
*** signifies p < 0.001).  
Fig. 4. EV calcification growth and maturation. a) Energy-dispersive x-ray 
spectroscopic analyses (EDS, insert) of dense aggregate structures isolated from a 
synthetic collagen hydrogel identified by SEM. (scale = 500 nm) b,c) TEM images 
of calcifying structures isolated from synthetic collagen hydrogels with selected-
area electron diffraction (d, insert). (scale = 200 nm) d) Identification of calcific 
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mineral for FTIR analysis (yellow arrows) from collagen hydrogels in bright field 
image. e) Composite bright field image of human carotid atherosclerotic plaque 
showing scanned FTIR scanned area (box). f) Magnified image of FTIR scanned 
area of human carotid atherosclerotic plaque with identifiable large calcification 
regions (red dashed arrow) and microcalcifications (blue arrow). g) FTIR 
absorbance spectra of mineral from EVs incubated without collagen (lightest blue 
spectra lines) or with hydrogels of 0.1 mg/ml collagen (medium blue spectra lines) 
or 1 mg/ml collagen (darkest blue spectra lines), and FTIR absorbance spectra of 
large calcification (dark red spectrum line) and microcalcification (light blue 
spectrum line). 
Fig. 5. Collagen entrapment of calcifying EVs. a) Confocal reflection image of 
layered hydrogel containing a border between high and low density collagen. b) 
Confocal fluorescence image of layered hydrogel 3 days following the introduction 
of green-labeled EVs aggregating with blue-labeled EVs (arrows) added 1 day later. 
c) Confocal fluorescence image of layered hydrogel 7 days following the addition of 
green-labeled EVs and 6 days following the addition of blue-labeled EVs. Red 
fluorescence indicates calcification at border between collagen densities (arrows). 
d) Picrosirius red colorimetric assay of collagen accumulation in human coronary 
artery SMCs cultured in control and calcifying media. (n=3, Student’s t-test, * 
signifies p < 0.05) e) 3D reconstruction from confocal z-stack images of collagen 
(green) and calcification (red) in SMCs cultured in calcifying media for 14 days. f) 
3D reconstruction from confocal z-stack images of collagen (green) and 
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calcification (red) in SMCs cultured in calcifying media for 21 days. g) Profile view 
of 21 day 3D reconstruction. h) Image from confocal z-stack image and orthogonal 
view of all z-stack images of collagen stained with a custom probe (green) and 
calcification identified by a near-infrared calcium tracer (red) in SMCs cultured in 
control media for 21 days. i) Image from confocal z-stack image and orthogonal 
view of all z-stack images of collagen (green) and calcification (red) in SMCs 
cultured in calcifying media for 21 days. j) Magnified confocal z-stack image of 
calcification within SMC-produced collagen (scale = 1 µm).   
Fig. 6. In vivo models of calcification growth. a) Intravital imaging of an apoE-/- 
mouse carotid artery at 20 weeks shows spotty microcalcifications (arrow) that are 
replaced by large calcification (dashed arrow) at 30 weeks. b) Quantification of 
calcification area (pixels) in carotid arteries of Apoe-/- mice at 20 and 30 weeks 
measured by intravital microscopy. Lines connect the same artery measured at 
each time point. (n = 6 different mice, paired t test, * signifies p < 0.05) c) Confocal 
fluorescence image of calcification within an atherosclerotic plaque from a 
histological section of an Apoe-/- mouse. The mouse received an intravenous inject 
of the fluorescent calcium tracer calcein green at 20 weeks (arrows) followed by an 
intravenous injection of the fluorescent calcium tracer alizarin red S at 23 weeks 
(dashed arrow). (scale = 10 µm) d) Representative images of collagen (identified 
by picrosirius red staining) and calcification (identified by near infrared 
fluorescence staining) shows large gaps in collagen (arrow) and corresponding 
large calcification (dashed arrow) in Apoe-/- mice. Apoe-/- / Mmp13-/- mice exhibit 
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more dense collagen and no calcification. e) Quantification of average gap area 
between collagen fibers in Apoe-/- and Apoe-/- / Mmp13-/- mice. (n = 8 mice per 
group, Student’s t-test, * signifies p < 0.05) f) Quantification of the area of each 
calcification identified in Apoe-/- and Apoe-/- / Mmp13-/- mice. (n = 8 mice per group, 
Mann-Whitney U test , * signifies p < 0.05) g) Schematic of proposed link between 
collagen content and calcification morphology. 
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Methods 
MicroCT of coronary arteries 
Human coronary artery specimens were scanned using a high-resolution micro-
computed tomography (µCT) system (SkyScan 1172). µCT system energy settings 
were chosen to increase the contrast between soft tissue, atheroma’s lipid content, 
and the mineralized tissue. Each scan produced approximately 8,000 2-
dimensional slices of 2,000 x 2,000 in-plane matrix, with 2.1-µm isotropic voxel 
resolution and 8-bit gray levels. The 2-dimensional slices were then used to create 
a 3-dimensional view of the artery specimens. 
 
Histological analyses 
Atherosclerotic carotid arteries (n=30) were obtained from patients undergoing 
endarterectomy surgery or from autopsy at Brigham and Women’s Hospital 
according to Institutional Review Board protocols. Samples were embedded in 
OCT compound and stored at -80 oC until use. Tissue was cut into 7 µm-thin 
sections for further analyses. Either a near-infrared bisphosphonate-based calcium 
tracer (OsteoSense 680, Perkin Elmer) or von Kossa phosphate staining was used 
to identify calcification within the sections. The calcium tracer was diluted 1:100 
from the original stock and was applied to the sections overnight at 4 oC. Collagen 
in the plaques was identified by staining sections with either a fluorescently 
conjugated collagen probe or utilizing picrosirius red staining and imaging with 
polarized light microscopy. When visualized under polarized light, picrosirius red 
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exhibits birefringence that distinguishes mature thick collagen bundles (yellow-
orange hue) from immature or disrupted thin collagen fibers (green hue)43. Prior to 
bright field, polarized light, or confocal imaging, sections were washed in PBS and 
embedded in mounting medium containing DAPI (Vector Laboratories). 
 
Two photon and confocal microscopy 
Second harmonic generation using two photon microscopy (Zeiss LSM 780 NLO) 
was employed to image collagen fibers within non-sectioned human carotid 
arteries. Following resection, the arteries were fixed for 48 h in 4% 
paraformaldehyde at 4 oC. The intact arteries were then washed in PBS and cut 
longitudinally into two portions to reveal the lumen face of the vessels. The arteries 
were then incubated with a near-infrared bisphosphonate-based calcium tracer 
(OsteoSense 680, Perkin Elmer) diluted 1:100 from the original stock for 48 h at 4 
oC. Following this incubation, the arterial segments were washed thoroughly with 
PBS and the media sides of the arteries were affixed to 6 cm diameter cell culture 
dishes using super glue such that the lumen sides of the arteries were facing up. 
PBS was added to completely submerge the segments. Optical section images 
were collected from the lumen side of the artery up to 300 µm into the plaque using 
a step size of 1 µm. This method allowed us to simultaneously image calcification 
and collagen orientation in plaques without disruptive effects of histological 
sectioning. Collagen was identified by analysis of second harmonic generation 
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signal, and calcification was delineated using continuous-wave confocal 
microscopic imaging of the near-infrared calcium tracer. Second harmonic signal 
was generated by tuning the Mai Tai Ti:sapphire laser to 850 nm and collecting the 
resultant tissue emission at 425 nm. These images were overlaid with 
corresponding optical sections of fluorescent detection of the near-infrared 
bisphosphonate-based calcium tracer using continuous wave confocal imaging. 
Continuous wave confocal microscopy (Nikon A1) was used to image histological 
sections of human carotid arteries and collagen hydrogels. Fluorescent images 
were obtained at specific excitation and emission wavelengths using the imaging 
software. Confocal reflection images were utilized to image collagen fibers within 
the hydrogels and were collected by setting the excitation wavelength to 514 nm 
and collecting the emitted light using a 520/10 nm band pass filter. 
 
Quantitative image analyses 
To overlay microcalcifications identified by bright field histological imaging onto 
polarized images of collagen fibers, we utilized a modified image analysis algorithm 
based upon our published hue saturation value program available at 
cics.partners.org44. Our custom software identified microcalcifications that exhibit a 
brown hue following von Kossa staining. These microcalcifications were assigned a 
blue pseudo-color and overlaid onto the corresponding polarized light of picrosirius 
red stained collagen fibers wherein mature collagen fibers were pseudo-colored 
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red and immature collagen fibers were pseudo-colored green. A similar analysis 
was utilized to identify collagen fibers in apoE-/- / MMP13-/- mice. Inversion of the 
images allowed identification and quantification of intercollagen area. 
A custom image analysis algorithm (MatLab) helped quantify the amount of 
collagen surrounding microcalcifications observed within the atherosclerotic 
plaques of carotid arteries resected from 9 different human patients. MatLab code 
can be provided by the corresponding author. Microcalcifications were identified as 
regions with more than 4 connected pixels positive for fluorescence from the 
bisphosphonate calcium tracer. A control area of 200 µm2 was analyzed for 
collagen content surrounding each microcalcification. The normalized collagen 
amount was calculated by dividing the pixels of collagen fluorescence by the total 
pixels within the region. A similar custom algorithm was used to quantify the 
volume of EV aggregates observed within collagen hydrogels; for these analyses, 
however, z-stack optical sections were used to identify the 3-dimensional structure 
of the aggregates. The average aggregate volume for each gel was determined, 
and 4 independent hydrogels of each collagen concentration considered were 
analyzed.  
 
Density-dependent color SEM 
For density-dependent color scanning electron microscopy (DDC-SEM) imaging, 
histologically sectioned samples, intact collagen hydrogels, or collagenase isolated 
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hydrogel components on a glass slide were secured to an aluminum sample holder 
with carbon tape, and silver paint was applied to the area immediately surrounding 
each sample, which was then coated with 5nm carbon (Quorum Technologies 
Turbo-Pumped Thermal Evaporators model K975X) and 5nm chromium in a 
sputter coater (Quorum Technologies Sputter Coater model K575X). Following the 
coating procedure, samples were imaged by an SEM (Gemini 1525 FEGSEM), 
operated at 10 kV. The instrument was equipped with both an inlens detector that 
recorded secondary electrons, and a backscatter electron detector. The DDC-SEM 
images were obtained by imaging a region in inlens mode and subsequently 
imaging the same region in backscatter mode. Using ImageJ software, both 
images were stacked and the inlens image was assigned to the green channel 
whereas the backscatter image was assigned to the red channel. 
 
Elemental and mineral structure analyses 
Energy-dispersive x-ray spectroscopy was used to characterize mineral content in 
both histological sections of calcified human carotid arteries and calcific structures 
from collagen hydrogels. The calcium to phosphate ratio determined by EDS 
commonly identifies the type of mineral present in calcified materials. For the 
collagen hydrogel analyses, 1 mg/ml collagenase in PBS was used to digest the 
collagen following the experimental incubation period, and the calcified EV 
aggregates from the hydrogels were collected by ultracentrifugation at 100,000 x g 
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for 40 min. Following the EDS analyses, the structures were sectioned using a 
focused gallium ion beam, and selected-area electron diffraction and transmission 
electron microscopy (TEM) were utilized to assess the crystallinity of the structures. 
Fourier transform infrared spectroscopy (Bruker, FTIR) was also utilized to perform 
elemental analyses of both histological sections of calcified human carotid arteries 
and calcific structures from collagen hydrogels. The FTIR system contains a 
motorized stage and polarized optical microscope to identify regions of interest. 
Attenuated total reflectance mode (single bounce Ge crystal) was used to collect 
spectral data in a range from 4,000 to 600 cm-1.  
 
Cell culture and EV collection 
Human coronary artery smooth muscle cells (SMCs; PromoCell) were grown to 
confluence and cultured in control media consisting of DMEM with 10% fetal 
bovine serum and 1% penicillin/streptomycin or a calcifying media consisting of 
control media supplemented with 10 nM dexamethasone, 100 µM L-ascorbic acid, 
and 10 mM β-glycerolphosphate. The media were replaced every two days. The 
SMCs were cultured for at least 14 days, a time point sufficient to induce calcific 
differentiation of the cells in the calcifying media45. After the prescribed culture 
period, the culture media were replaced with media containing the same 
components but lower fetal bovine serum (0.1%) to reduce the noise caused by the 
presence of vesicles within the serum compared to the vesicles of interest released 
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by SMCs. After 24 h, the low serum media was collected after centrifugation at 
1,000 x g for 5 min to remove potential cellular contaminants and large vesicles 
such as apoptotic bodies. The resulting supernatant was then stored at – 80 oC 
prior to further processing. EVs were isolated from the supernatant by 
ultracentrifugation at 100,000xg for 40 min and resuspended in fresh control or 
calcifying media. A portion of the conditioned media for each sample was reserved 
for nanoparticle tracking analysis to ensure the absence of larger vesicles such as 
apoptotic bodies.  
 
Collagen hydrogel experiments 
Collagen hydrogels were made by slowly raising the pH of high concentration rat 
tail collagen stored in a solution of acetic acid (BD Biosciences) to 7-8. In this pH 
range, the collagen forms a hydrogel network. The neutralized collagen solution 
was then added to chambered coverglass wells (LAB-TEK, #1.5 borosilicate). EVs 
in SMC conditioned media with 0.1% FBS were then added to the collagen network 
and incubated at 37 oC for the indicated time period. One day prior to imaging, a 
near-infrared based bisphosphonate calcium tracer (OsteoSense 680, Perkin 
Elmer) was added to the hydrogels and incubated overnight at 37 oC. The resulting 
aggregation and calcification processes were imaged by confocal fluorescence and 
reflection microscopy. 
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To create layered collagen hydrogels, a 15 µl volume of 2.5 mg/ml collagen 
solution was pipetted onto the surface of a chambered well glass. After 1 h 
incubation at 37 oC, a 15 µl volume of 0.1 mg/ml collagen solution was placed 
directly adjacent to the first cast hydrogel such that the two drops formed a 
continuous border. CellTracker (Invitrogen) dyes were used to fluorescently label 
EVs prior to addition to the hydrogels. After crossing the cellular plasma membrane, 
CellTracker fluorescent dyes are converted by intracellular enzymes to a 
membrane impermeant form that is well retained in the cellular cytoplasm. We 
added CellTracker to the conditioned media containing EVs from SMCs at 2.5 µM 
for 30 min. Chromatography columns (GE Healthcare PD-10 columns) helped 
remove the dye solution per manufacturer’s protocol. After the EV portion was 
collected from the column, the EVs were pelleted by ultracentrifugation at 100,000 
x g for 40 min and re-suspended in dye free media prior to being added to collagen 
hydrogels. 
 
Nanoparticle tracking analyses (NTA) 
NTA by NanoSight LM10 (Malvern Instruments Ltd, Malvern, UK) assessed vesicle 
size and concentration within the media samples46. Calcific SMC-derived EVs 
collected from conditioned media by ultracentrifugation at 100,000 x g were 
resuspended in 1 ml calcifying media and divided into five 200 µl portions. One 
portion was collected for initial time point analyses. Aggregation was detected by 
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NTA in the remaining portions incubated at 37 oC for 1, 3, 5, or 7 days. NTA 
determines nanoparticle number and size distributions from the Brownian motions 
of objects illuminated by laser light47. The samples were diluted 1:7 in PBS prior to 
injection into the NanoSight chamber. Samples were continuously injected via a 
syringe pump (Malvern), and five NTA videos were collected for 1 min each. The 
camera gain was set at a constant value of 9, and the threshold value for vesicle 
detection was set to 2. The resultant size and concentration output data from each 
video were averaged to generate the final distribution for each sample. 
 
EV mineralization assay 
Utilization of a fluorescence-based dye (OsteoImage, Lonza) allowed quantification 
of mineral within EVs. Briefly, isolated EVs were resuspended in 200 µl diluted 
OsteoImage dye (according to manufacturer protocol) for 30 min at room 
temperature. The dye was then removed via ultracentrifugation and the vesicles 
were washed twice in OsteoImage wash buffer using 100,000 x g 
ultracentrifugation for 40 min. After the final wash, the pellet was resuspended in 
100 µl OsteoImage wash buffer and fluorescence intensity was measured using a 
plate reader. 
 
Sircol quantitative collagen assay 
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Collagen content of SMCs in culture was determined in the extracellular matrix 
using Sircol Soluble Collagen Assay (Biocolor, Northern Ireland, UK) based on 
picrosirius red dye. Briefly, after a washing step, cells were incubated with 0.5 M 
acetic acid and 0.1 mg/ml pepsin overnight. After neutralization, collagen was 
concentrated overnight. The next day, Sircol reagent was added to bind collagen. 
After two washing steps the Sircol dye was released from the collagen-dye 
complex by alkali reagent and absorption at 555 nm was measured.  
 
Structure Illumination Microscopy 
Structure illumination microscopy (Zeiss ELYRA Super-Resolution) allowed high 
resolution imaging of fluorescently labeled EVs within collagen hydrogels. Prior to 
imaging, a near-infrared based bisphosphonate calcium tracer (OsteoSense 680, 
Perkin Elmer) was added to the hydrogels and incubated overnight at 37 oC. To 
minimize refractive index mismatch, hydrogels were serially immersed in solutions 
with increasing concentration of 2,2’-thiodiethanol (TDE) (Sigma Aldrich) (10%, 
25%, 50%, 97% three times, all at pH 7.5 +/-1) as previously described48 and 
mounted in 95% TDE medium with 2.4% anti-fade 1,4-Diazabicyclo[2,2,2]octane 
solution, or DABCO (Sigma Aldrich). Samples were covered with high precision 
cover glass (No. 1.5H, 170±5 μm) (Biosciencetools). SIM imaging improves the 
resolution of traditional fluorescence and confocal microscopy from approximately 
300 nm down to 100 nm49. 
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Calcification in mouse atherosclerotic plaques 
The intravital imaging, fluorescence reflection imaging, and Apoe-/- / Mmp13-/- 
mouse data reported in this study were obtained from unused tissues or analyses 
from previous studies as cited, and all experiments were performed in accordance 
with procedures approved by Institutional Animal Care and Use Committees. For 
intravital imaging, 10 week old Apoe-/- mice consumed an atherogenic diet for 10 
weeks. Mice received intravenous injection of a bisphosphonate-derivatized near-
infrared imaging agent (OsteoSense) according to manufacturer’s protocol 24 h 
before imaging. A small incision revealed the mouse carotid artery, and an 
intravital laser scanning microscope detected fluorescence following excitation at 
748 nm. Following suturing of the incision, the mice resumed the atherogenic diet 
for 10 additional weeks. Repeating the intravital imaging procedure on the same 
carotid artery imaged 10 weeks earlier allowed monitoring of the calcification 
progression. 
A two-step 5/6 nephrectomy procedure created CKD-Apoe-/- mice. These mice also 
received an atherogenic diet at 10 weeks of age for 10 weeks. The mice were 
euthanized 24 h following intravenous injection of the near-infrared 
bisphosphonate-derivatized agent, and excision of heart and major arteries allowed 
fluorescence reflectance imaging to map the cardiovascular osteogenic activity. 
Control Apoe-/- received a sham surgery but retained normal kidney function. 
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Calcein green and alizarin red S allowed tracing of calcification growth in 
atherosclerotic plaques apoE-/- mice over time. Beginning at 10 weeks of age, the 
mice received an atherogenic diet for 20 weeks. An intravenous injection of calcein 
green labeled the existing calcification in situ. The mice continued to receive the 
atherogenic diet for 3 additional weeks followed by an intravenous injection of 
alizarin red S to label the calcification at this time point. Mice were euthanized 
three days later. Confocal microscopy of histological sections imaged the 
fluorescence signal liberated from these two dyes. 
Age-matched Apoe-/- controls and 8-to-10 week old Apoe-/- / Mmp13-/- mice 
received an atherogenic diet for 24 weeks. Following euthanization, histopathologic 
sectioning of the aortic root allowed for analyses of collagen, TNAP, and 
calcification within atherosclerotic plaques. TNAP was identified using a 
colorimetric substrate kit (VECTOR Laboratories), and calcium was extracted from 
four histological sections per mouse per group through an overnight incubation at 
37 oC with 0.6 M hydrochloric acid. Calcium in the extract was measured using 
colorimetric assay kit (BioVision).  
 
Statistical analyses 
Quantitative data are given as mean ± standard deviation, and n indicates the 
number of independent experiments. Neither the experiments nor outcomes were 
blinded during the study. Statistical packages within GraphPad Prism determined 
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data normality and estimated the variance between groups of data. Statistical 
differences were determined using a one-way ANOVA with Bonferroni’s post hoc 
test, and single group comparisons using a Student’s t test with significance 
considered as p<0.05. Unless otherwise noted, statistical differences from in vitro 
experiments were determined using three different human SMC donors to ensure 
that observations were not skewed by a single outlier SMC culture. Correlative 
analyses were performed using a Pearson correlation method. A paired t test 
determined significance in the time course intravital imaging experiments. A Mann-
Whitney U test assessed significant differences in the non-normally distributed 
results obtained from the comparison of calcification areas in Apoe-/- and Apoe-/- / 
Mmp13-/- mice. 
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